Two different medications for the same condition.
Methadone and Suboxone are both used to treat opioid use disorder. Both reduce withdrawal and cravings. Both are evidence-based.
The difference is pharmacology, access, and how treatment is organized.
What they have in common
Both are medication-based treatment for opioid use disorder.
Both medications stabilize opioid receptors, reduce cravings, and prevent withdrawal. Both are associated with reduced overdose risk and improved retention in treatment.
Neither is a cure. Both are part of ongoing medical management.
Methadone
A full opioid agonist, dispensed at a federally regulated program.
Methadone for opioid use disorder is dispensed through federally regulated opioid treatment programs (OTPs). Patients typically visit the OTP in person, often more frequently in the first weeks of treatment. Under SAMHSA’s 2024 final rule (42 CFR Part 8), take-home doses can be earned more quickly than under prior rules — up to about 28 days of take-home methadone for stable patients after the early phase of treatment.
Methadone has a long clinical history and is highly effective for many patients with opioid use disorder, including those who benefit from the structure of an OTP setting.
Suboxone
A partial agonist, prescribed by a physician.
Suboxone is a partial opioid agonist. It can be prescribed by a physician and picked up at a pharmacy. It does not require daily clinic visits.
Suboxone has a ceiling effect, which means the risk of respiratory depression is lower than with methadone. It can be prescribed through telehealth.
Key differences
How they compare.
Access: Methadone is dispensed at a federally regulated opioid treatment program (OTP), often with frequent visits early in treatment that become less frequent as patients are eligible for take-home doses. Suboxone is prescribed by a physician and filled at any pharmacy.
Pharmacology: Methadone is a full agonist. Suboxone is a partial agonist with a ceiling effect.
Daily obligation: Methadone requires physical presence at a dispensing clinic, especially early in treatment. Suboxone does not.
Risk profile: Methadone carries a higher risk of overdose during dose adjustment. Suboxone's ceiling effect reduces this risk.
Effectiveness: Both are effective. Some patients respond better to one than the other.
Telehealth
Suboxone is available through telehealth; methadone generally is not.
Suboxone can be prescribed through a telehealth visit and filled at any pharmacy. Methadone treatment is tied to a licensed opioid treatment program (OTP). Under SAMHSA’s 2024 rule changes, some OTPs may use audio-visual telehealth for parts of care — for example, the initial assessment by a non-medical-director practitioner, or ongoing follow-up — but methadone itself is still dispensed at the OTP or as authorized take-home doses. There is no mail-order or pharmacy-fill model for methadone the way there is for Suboxone.
For patients without a nearby methadone OTP, or whose circumstances make frequent in-person OTP visits difficult, Suboxone through telehealth is often the more practical option.
How the choice is made
It depends on clinical history and access.
For many patients, Suboxone is a practical first step. It can be started quickly, does not require daily clinic visits, and has a favorable safety profile.
Methadone may be more appropriate for patients who have not responded to buprenorphine, or who benefit from observed daily dosing.
The decision is clinical and made with a physician.
Common questions
Questions people usually have.
Is Suboxone better than methadone?
Neither is universally better. They have different pharmacology, different access models, and different risk profiles. The right choice depends on clinical factors.
Can you switch from methadone to Suboxone?
Yes, but the transition requires careful medical management because of the risk of precipitated withdrawal. This is not something to attempt without a physician.
Can you get methadone through telehealth?
Largely no. Methadone for opioid use disorder is dispensed at federally regulated opioid treatment programs (OTPs). Under SAMHSA’s 2024 final rule, audio-visual telehealth may be used for some parts of OTP care — but methadone itself is still dispensed at the OTP or as authorized take-home doses. There is no general “methadone by mail” telehealth model the way there is for Suboxone.